NCT06335797 Optimization of Postoperative Bowel Habits
| NCT ID | NCT06335797 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Constipation |
| Study Type | INTERVENTIONAL |
| Enrollment | 88 participants |
| Start Date | 2024-10-16 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 88 participants in total. It began in 2024-10-16 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Project is a trial, in which women undergoing vaginal surgery for pelvic organ prolapse will be randomized 1:1 to a postoperative bowel regimen of either oral senna or rectal bisacodyl suppository.
Eligibility Criteria
Inclusion Criteria: * Women ages 18 and older scheduled to undergo vaginal pelvic organ prolapse repair Exclusion Criteria: * Women younger than 18 years old * Those unable to provide consent * Preexisting chronic laxative use * Conditions that could affect bowel function including, inflammatory bowel disease, irritable bowel syndrome, colorectal cancer, rectovaginal fistula; concurrent bowel surgery; intraoperative bowel injury
Contact & Investigator
Candace Parker-Autry, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT06335797 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Constipation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06335797 currently recruiting?
Yes, NCT06335797 is actively recruiting participants. Contact the research team at cmezes@wakehealth.edu for enrollment information.
Where is the NCT06335797 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT06335797 clinical trial?
NCT06335797 is sponsored by Wake Forest University Health Sciences. The principal investigator is Candace Parker-Autry, MD at Wake Forest University Health Sciences. The trial plans to enroll 88 participants.